FDA approves Duramed’s generic treatment for edema, glaucoma and epilepsy
BIG FLATS, N.Y. The Food and Drug Administration has approved a generic drug for treating edema, glaucoma and epilepsy.
X-GEN Pharmaceuticals announced in late December that the FDA had approved its acetazolamide for injection USP, a generic version of Duramed Pharmaceuticals’ Diamox. The drug is supplied in vials as a sterile powder, with 500 mg in each vial.
“Currently, there is only one supplier of acetazolamide for injection USP,” X-GEN president and CEO Susan Badia said. “Our launch of this product will ensure consistent supply and steady, competitive price levels.”
Researchers test administering medication using nanotechnology, gold
NEW YORK Researchers have developed a way to use tiny particles of gold to control the administration of drugs for diseases such as cancer, according to a study published in the journal ACS Nano.
The researchers, at the Massachusetts Institute of Technology, created a device that shines infrared light on particles of gold coated with medicine.
The particles vary in size, causing them to melt at different rates depending on the intensity of the light.
The researchers said the device would allow medicine to target specific areas of the body at specific rates, thus minimizing damage to healthy tissue.
N.J. tests new law requiring vaccinations for school-age children
TRENTON, N.J. New Jersey will find out this week if its new law requiring flu vaccinations for schoolchildren has worked, according to published reports.
The state is the first in the country to require schoolchildren to receive flu vaccinations, between the ages of 6 months and 5 years. It required the children to receive the vaccinations by Dec. 31. Children who have not been vaccinated will not be allowed to attend school.